共查询到20条相似文献,搜索用时 9 毫秒
1.
目的观察自体骨髓间充质干细胞(BMSC)移植治疗肝硬化难治性腹水的疗效及安全性。方法对2010年9月至2013年9月入住南京总医院消化内科经正规利尿、补充白蛋白达3个月以上且疗效欠佳的32例肝硬化腹水患者,在原有治疗基础上加用自体BMSC移植治疗,分别于治疗前、治疗后1个月及3个月观察腹围、体重、24 h尿量、血清尿素氮、肌酐、尿钠及血清蛋白浓度等指标变化。采用方差分析、配对t检验和Wilcoxon检验进行统计学分析。结果治疗前,患者体重、腹围、24 h尿量及血清尿素氮、肌酐、血清总蛋白、血清白蛋白及尿钠排出水平分别为(66.9±3.8)kg、(94.0±3.6)cm、(966±138.7)ml、(10.5±3.6)mmol/L、(112.4±30.6)μmol/L、(63.8±4.2)g/L、(32.1±2.7)g/L、(43.8±2.3)mmol/L;治疗后1个月,分别为(66.0±3.9)kg、(93.0±3.6)cm、(1032±154.8)ml、(9.9±3.2)mmol/L、(104.8±25.6)μmol/L、(65.3±3.5)g/L、(32.6±2.9)g/L、(44.7±2.7)mmol/L;治疗后3个月,分别为(56.2±3.7)kg、(80.5±4.5)cm、(1530±180.6)ml、(7.9±2.3)mmol/L、(88.7±22.2)μmol/L、(72.8±3.3)g/L、(39.2±1.5)g/L。3个组别8个指标均数比较有统计学意义(F=78.194、117.689、120.527、6.558、6.712、54.827、83.421、493.776,均P=0.000)。治疗后1个月与治疗前水平差异无统计学意义(t分别为0.587、0.636、0.559、0.556、0.678、0.522、0.611、0.592;P=0.331、0.266、0.101、0.416、0.25、0.107、0.447);而治疗后3个月,患者的体重、腹围较治疗前及治疗后1个月均明显减少,24 h尿量明显增加(与治疗前比较,t=3.722、3.784、3.821,与治疗后1个月比较,t=3.921、3.834、3.944,均P=0.000),血清尿素氮、肌酐水平较治疗前及治疗后1个月均明显下降;而血清总蛋白、白蛋白及尿钠排出水平均明显升高(与治疗前比较,t=2.182、2.338、2.182、2.412、2.136,P尿素、肌酐=0.001,其余P 相似文献
2.
Ming-Fang Wang You-Bing Li Xiao-Juan Gao Hao-Yang Zhang Su Lin Yue-Yong Zhu 《World journal of stem cells》2018,10(10):138-145
AIM To evaluate the long-term efficacy and safety of autologous stem cell transplantation(SCT) for decompensated liver cirrhosis.METHODS Consecutive patients with decompensated liver cirrhosis were included and assigned into the SCT group and non-transplantation(non-SCT) group according to whether they received SCT treatment. Patients werefollowed up for ten years. The long-term survival rate and incidence of hepatocellular carcinoma(HCC) were compared between groups. 相似文献
3.
《Cytotherapy》2014,16(11):1575-1583
Background aimsCurrently, there is no treatment for decompensated liver cirrhosis except for liver transplantation. The safety and effect on liver function of a transjugular intrahepatic portosystemic shunt (TIPS) with and without autologous bone marrow cell (BMC) infusion in patients with decompensated liver cirrhosis were determined.MethodsTen patients who were diagnosed with decompensated liver cirrhosis during the period from September 2011 to July 2012 were enrolled in this study. The patients underwent TIPS (TIPS group) or combined treatment with TIPS and BMC infusion through the hepatic artery (TIPS+BMC group). All patients were monitored for adverse events, liver function and complications caused by portal hypertension during a period of 52 weeks.ResultsThe number of infused BMCs was 2.65 ± 1.20 ×109. Significant improvements in the serum levels of albumin and total bilirubin and decreased Child-Pugh scores were observed in patients treated with both TIPS and BMCs (P < 0.05), whereas no such changes were observed in the TIPS group. Endoscopic findings showed that varices in the esophagus and the gastric fundus were alleviated after either treatment. All 10 patients showed a complete or partial resolution of ascites at 4 weeks. No major adverse effects were noted during the follow-up period for patients in either group.ConclusionsTIPS combined with BMC infusion is clinically safe; the treatment improved liver function and alleviated complications caused by portal hypertension; therefore, this combination has potential for treatment of patients with decompensated liver cirrhosis. 相似文献
4.
Yuesi Zhong Zhaofeng Tang Ruiyun Xu Nan Lin Meihai Deng Heping Fang Jizhong Lin Kangshun Zhu Yong Liu Zhuang Kang 《Cytotherapy》2013,15(10):1266-1274
Background aimsAssessing mesenchymal stromal cells (MSCs) after grafting is essential for understanding their migration and differentiation processes. The present study sought to evaluate via cellular magnetic resonance imaging (MRI) if transplantation route may have an effect on MSCs engrafting to fibrotic liver of rats.MethodsRat MSCs were prepared, labeled with superparamagnetic iron oxide and scanned with MRI. Labeled MSCs were transplanted via the portal vein or vena caudalis to rats with hepatic fibrosis. MRI was performed in vitro before and after transplantation. Histologic examination was performed. MRI scan and imaging parameter optimization in vitro and migration under in vivo conditions were demonstrated.ResultsStrong MRI susceptibility effects could be found on gradient echo-weighted, or T21-weighted, imaging sequences from 24 h after labeling to passage 4 of labeled MSCs in vitro. In vivo, MRI findings of the portal vein group indicated lower signal in liver on single shot fast spin echo-weighted, or T2-weighted, imaging and T21-weighted imaging sequences. The low liver MRI signal increased gradually from 0–3 h and decreased gradually from 3 h to 14 days post-transplantation. The distribution pattern of labeled MSCs in liver histologic sections was identical to that of MRI signal. It was difficult to find MSCs in tissues near the portal area on day 14 after transplantation; labeled MSCs appeared in fibrous tuberculum at the edge of the liver. No MRI signal change and a positive histologic examination were observed in the vena caudalis group.ConclusionsThe portal vein route seemed to be more beneficial than the vena caudalis on MSC migration to fibrotic liver of rats via MRI. 相似文献
5.
CHEN YiHuan TENG XiaoMei CHEN WeiQian YANG JunJie YANG ZiYing YU YunSheng SHEN ZhenYa 《中国科学:生命科学英文版》2014,57(2):195-200
It is still unclear whether the timing of intracoronary stem cell therapy affects the therapeutic response in patients with myocardial infarction.The natural course of healing the infarction and the presence of putative homing signals within the damaged myocardium appear to favor cell engraftment during the transendothelial passage in the early days after reperfusion.However,the adverse inflammatory environment,with its high oxidative stress,might be deleterious if cells are administered too early after reperfusion.Here we highlight several aspects of the timing of intracoronary stem cell therapy.Our results showed that transplantation of bone marrow mesenchymal stem cells at 2 4 weeks after myocardial infarction is more favorable for reduction of the scar area,inhibition of left ventricular remodeling,and recovery of heart function.Coronary injection of autologous bone marrow mesenchymal stem cells at 2 4 weeks after acute myocardial infarction is safe and does not increase the incidence of complications. 相似文献
6.
杨吏王燕 《中华细胞与干细胞杂志(电子版)》2018,8(6):355-360
目的探讨自体骨髓干细胞移植联合奥扎格雷对糖尿病足(DF)的临床疗效。
方法选取2017年7月至2018年8月期间于重庆市大渡口区人民医院收治的99例DF患者为研究对象,随机分为奥扎格雷组、移植组与联合组3组各33例。全部患者入院后均给予DF的常规治疗,奥扎格雷组、移植组、联合组分别给予奥扎格雷、自体骨髓干细胞移植、自体骨髓干细胞移植联合奥扎格雷,比较干预前、干预后12周的临床症状体征、DF严重程度、生存质量的变化,以及干预后12周的新生侧支血管的分级情况。定性资料采用χ2检验或Wilcox秩和检验,定量资料组内干预前后比较采用配对t检验,多组比较先采用方差分析,然后采用Tukey检验进行两两比较。采用Pearson相关系数探讨截肢组患者生活质量评分的相关因素。
结果3组患者干预前的基线资料、疼痛、冷感、间歇性跛行的评分、踝肱指数(ABI)、Wagner分级、糖尿病特异性生活质量量表(DSQL)各维度评分与总分比较,差异无统计学意义(P > 0.05),具有可比性。组内比较,3组干预后的疼痛、冷感、间歇性跛行的评分、DSQL生理功能、心理(精神)因素、社会关系等维度评分与总分均低于干预前,Wagner分级、ABI优于干预前,差异有统计学意义(P < 0.05)。组间比较,联合组干预后的疼痛、冷感、间歇性跛行的评分、DSQL生理功能、心理(精神)因素等维度评分与总分分别为0.83±0.36、0.83±0.31、1.36±0.63、8.9±3.2、7.5±2.5、23.7±9.2,均低于奥扎格雷组的1.13±0.39、1.26±0.59、1.89±0.73、12.5±5.2、10.1±3.1、31.7±8.8及移植组的1.08±0.33、1.11±0.55、1.72±0.60、10.9±3.6、9.3±3.3、28.8± 7.6,差异有统计学意义(F = 5.001、5.598、3.953、2.230、9.610,P均< 0.05)。联合组干预后的ABI为0.55±0.21,高于奥扎格雷组的0.43±0.20及移植组的0.42±0.16,差异有统计学意义(F = 4.051,P < 0.05)。联合组干预后的社会关系维度评分、Wagner分级为1级的比例分别为5.0±2.1、81.8%,高于奥扎格雷组的6.3±2.3、54.5%,差异有统计学意义(F = 3.953,χ2= 6.983,P均 < 0.05)。观察组干预后的新生侧支血管分级优于奥扎格雷组,差异有统计学意义(P < 0.05)。
结论自体骨髓干细胞移植联合奥扎格雷能缓解DF患者的临床症状,促进溃疡愈合,促进移植术后的血管新生,提高生存质量,值得临床推广应用。 相似文献
7.
Durable engraftment of genetically modified FVIII‐secreting autologous bone marrow stromal cells in the intramedullary microenvironment
下载免费PDF全文
![点击此处可从《Journal of cellular and molecular medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sze Sing Lee Jaichandran Sivalingam Ajit J. Nirmal Wai Har Ng Irene Kee In Chin Song Chin Yong Kiong Kristoffer A. Gales Frederic Chua Edgar M. Pena Bryan E. Ogden Oi Lian Kon 《Journal of cellular and molecular medicine》2018,22(7):3698-3702
Genetically modified FVIII‐expressing autologous bone marrow‐derived mesenchymal stromal cells (BMSCs) could cure haemophilia A. However, culture‐expanded BMSCs engraft poorly in extramedullary sites. Here, we compared the intramedullary cavity, skeletal muscle, subcutaneous tissue and systemic circulation as tissue microenvironments that could support durable engraftment of FVIII‐secreting BMSC in vivo. A zinc finger nuclease integrated human FVIII transgene into PPP1R12C (intron 1) of culture‐expanded primary canine BMSCs. FVIII‐secretory capacity of implanted BMSCs in each dog was expressed as an individualized therapy index (number of viable BMSCs implanted × FVIII activity secreted/million BMSCs/24 hours). Plasma samples before and after implantation were assayed for transgenic FVIII protein using an anti‐human FVIII antibody having negligible cross‐reactivity with canine FVIII. Plasma transgenic FVIII persisted for at least 48 weeks after implantation in the intramedullary cavity. Transgenic FVIII protein levels were low after intramuscular implantation and undetectable after both intravenous infusion and subcutaneous implantation. All plasma samples were negative for anti‐human FVIII antibodies. Plasma concentrations and durability of transgenic FVIII secretion showed no correlation with the therapy index. Thus, the implantation site microenvironment is crucial. The intramedullary microenvironment, but not extramedullary tissues, supported durable engraftment of genetically modified autologous FVIII‐secreting BMSCs. 相似文献
8.
目的探讨自体骨髓间充质干细胞(BM-MSCs)对二甲基甲酰胺(DMF)中毒致急性肝衰竭后肝功能延迟恢复患者的疗效和安全性。
方法1例DMF中毒性急性肝衰竭患者,在人工肝为主的内科综合治疗后肝功能持续得不到恢复时,采取患者骨髓,分离、培养制备BM-MSCs,经肝动脉介入输注到患者肝内,观察其临床表现、肝功生化、凝血、肝脏影像学、肝组织病理学等改变及BM-MSCs近期不良反应和远期的安全性。
结果BM-MSCs治疗后,患者持续不见好转的肝功生化指标开始改善,凝血功能恢复速度加快,凝血酶原活动度(PTA)逐渐恢复到40%以上,上腹部CT见肝脏再生结节较前增大,Child-Pugh分级由C级转为A级,终末期肝病模型(MELD)评分由21分降到7分;干细胞输注早期未出现相关的不良反应,8周后再生结节穿刺活检其病理特征为:肝细胞变性、坏死、纤维化、胆汁淤积与再生并存。随访3年患者肝功生化正常、肝硬化结节影像学观察无明显变化,未发生癌变。
结论BM-MSCs肝动脉介入治疗对DMF中毒致急性肝衰竭肝功能延迟恢复患者的肝功能改善具有一定促进作用,近期无明显不良反应,中远期安全性好。 相似文献
9.
目的 研究自体骨髓单个核细胞移植对股骨头坏死患者缺血状态的改善程度和治疗效果.方法 选取2004 年7 月至2010 年11 月期间187 例252 髋股骨头坏死患者,应用自体骨髓单个核细胞移植治疗,分别采集 187 例患者骨髓200 -360 ml,采用 Ficoll 密度梯度离心法分离单个核细胞,单个核细胞总数为(2.4 ~ 7.8)× 108 个,流式细胞仪检测 CD34+ 细胞和 CD133+ 细胞在所分离出的干细胞悬液中的含量分别为2.47﹪± 0.58﹪和1.29﹪± 0.35﹪,然后将单个核细胞用生理盐水制备成细胞悬液 20 - 30 ml,使用数字减影血管造影技术(DSA)行超选择性股骨头供血动脉内干细胞移植术.按世界骨循环研究学会(ARCO)对骨坏死分期,设自身前后对照观察疗效.移植术后第 3、6、12、24、36 和48 个月,根据髋关节 Harris 评分评价疗效,移植术后6 个月通过复查患者股骨头供血动脉 DSA,观察其新生血管形成情况,以后每隔 6 个月采用影像学方法观察股骨头形态学变化.结果 (1)临床疗效:对接受自体骨髓单个核细胞移植治疗的187 例患者随访 3 ~ 48(24.2 ± 4.5)个月,其中髋关节疼痛缓解者 158 例(占患者总数的 84.5﹪),髋关节功能改善者 146 例(占患者总数的 78.1﹪),行走间距延长者 149 例(占患者总数的 79.7﹪);(2)影像学检查:干细胞移植术后 6 个月187 例患者中54 例行股骨头供血动脉 DSA 检查,48 例显示供血动脉较移植术前明显增多、增粗,血流速度增快,12 ~ 24个月后 72 例患者股骨头区骨质病变获得改善.结论 超选择性动脉内骨髓单个核细胞移植方法简便、安全有效,对因缺血导致坏死的股骨头无再次损伤,能够有效治疗缺血性股骨头坏死. 相似文献
10.
Shaohui Pan Yu-Chen Chen Ning Zhao Xiang Feng Dan-Dan Yang Yongshen Wang Zi-Bing Jin 《Journal of cellular biochemistry》2019,120(8):13881-13892
Bone marrow stromal cells (BMSCs) are a unique population of multipotent cells that exhibit pluripotent properties to a certain extent and are significantly heterogeneous in terms of the cell population. We isolate a small cell subpopulation from bovine BMSCs, bovine small stem cells (bSSCs), and herein characterize their properties. The bSSCs are smaller in size and express nuclear Oct-4 and other pluripotency markers. In addition, when cultured in suspension conditions, bSSCs form three-dimensional spheres and display a strong capability for self-renewal and differentiation into cells from three germ layers. Notably, bSSCs display neural features with Sox1 and Pax6 expression. Using bSSCs as donor nuclear cells for somatic cell nuclear transfer, we further demonstrate that the developmental potential of cloned embryos in vitro is significantly increased. Our study identifies a new bovine bone marrow stromal cell–derived stem cell subtype that could have broad importance for developmental biology as well as great potential for regenerative medicine. 相似文献
11.
骨髓间充质干细胞(BMSC)是一种具有多向分化能力且能无限增殖的间质细胞,在肝脏疾病的作用已经得到证实。肝移植是目前治疗终末期肝病最为有效的方法,随着脂肪性供肝等边缘性供肝的增加,如何使边缘性供肝更好的发挥功能,成为了新的研究热点。研究BMSC对脂肪性供肝肝移植术后肝脏功能恢复的影响将为其在临床上的应用提供依据。 相似文献
12.
13.
《Cytotherapy》2014,16(11):1584-1589
Background aimsStem cell collection can be a major component of overall cost of autologous stem cell transplantation (ASCT). Plerixafor is an effective agent for mobilization; however, it is often reserved for salvage therapy because of its high cost. We present data on the pharmacoeconomic impact of the use of plerixafor as an up-front mobilization in patients with multiple myeloma (MM).MethodsPatients with MM who underwent ASCT between January 2008 and April 2011 at the Mount Sinai Medical Center were reviewed retrospectively. In April 2010, practice changes were instituted for patients with MM to delay initiation of granulocyte-colony-stimulating factor (G-CSF) support from day 0 to day +5 and to add plerixafor to G-CSF as an up-front autologous mobilization. Targets of collection were 5–10 × 106 CD34+ cells/kg.ResultsOf 50 adults with MM who underwent ASCT, 25 received plerixafor/filgrastim and 25 received G-CSF alone as an up-front mobilization. Compared with the control, plerixafor mobilization yielded higher CD34+ cell content (16.1 versus 8.4 × 106 CD34+ cells/kg; P = 0.0007) and required fewer sessions of apheresis (1.9 versus 3.1; P = 0.0001). In the plerixafor group, the mean number of plerixafor doses required per patient was 1.8. Although the overall cost of medications was higher in the plerixafor group, the cost for blood products and overall cost of hospitalization were similar between the two groups.ConclusionsUp-front use of plerixafor is an effective mobilization strategy in patients with MM and does not have a substantial pharmacoeconomic impact in overall cost of hospitalization combined with the apheresis procedure. 相似文献
14.
15.
目的观察失代偿期肝硬化患者行自体骨髓干细胞移植前粒细胞集落刺激因子(G-CSF)对骨髓干细胞的动员效果及安全性。方法在51例失代偿期肝硬化患者行自体骨髓干细胞经肝动脉移植术前,连续2 d给予G-CSF 4μg/(kg·d)动员骨髓干细胞。抽取骨髓的当日化验血常规、肝肾功等指标;从患者髂后上棘抽取骨髓150-200 ml,分离收集骨髓单个核细胞并计数,应用流式细胞仪检测CD34+细胞并计数,观察应用G-CSF期间不良反应的类型和发生率。患者治疗前后比较采用配对t检验进行统计学分析。结果G-CSF皮下注射后,外周血白细胞由术前(3.31±0.96)×10^9/L升至(11.35±1.92)×10^9/L(P〈0.01),骨髓单个核细胞数(1.91±0.83)×10^9/kg,CD34+细胞为(2.02±1.29)×10^7/kg;患者皮下注射后,发热率17.6﹪,体温最高38℃,停药后降至正常;腹部胀痛3例,四肢皮肤散发皮疹2例,均未给予特殊处理,2-3 d后恢复正常。结论给予G-CSF皮下注射后提取骨髓干细胞移植治疗失代偿期肝硬化的是一种临床确切有效的、安全的干细胞动员方法。 相似文献
16.
目的 探讨移植途径对骨髓间充质干细胞(MSCs)归巢及促进肝切除大鼠肝再生的影响.方法 建立肝切除大鼠模型,随机分为3 组,即肝切除对照组、尾静脉移植组和门静脉移植组.移植组分别经尾静脉和门静脉注射DAPI 标记的MSCs 约1.5×106/ 只,分别于第3 天和第9 天后采血清检测肝功能,第9 天处死大鼠取肝脏标本,并通过荧光显微镜观察两种移植途径对MSCs 向肝脏迁移的影响.结果 门静脉移植组(18.1 ± 3.4)个细胞/100 倍视野到肝脏归巢及定植的 MSCs 多于尾静脉移植组(7.6 ± 2.0)个细胞/100 倍视野,差异有统计学意义(P 〈 0.01).术后第9 天各组大鼠肝功能均有好转,丙氨酸氨基转移酶(ALT)及天冬氨酸氨基转移酶(AST)3 组之间对比差异无统计学意义(F = 2.822,1.046,P = 0.057,0.365,P 〉 0.05);但两移植组与单纯肝切除组比较血浆白蛋白(ALB)均有明显升高,差异具有统计学意义(F = 6.259,P = 0.006);尾静脉移植组与门静脉移植组两移植组之间相比,差异无统计学意义(P 〉 0.05).结论 移植途径对 MSCs 归巢、定植到肝脏有一定影响,门静脉途径优于外周静脉,MSCs 移植对肝大部切除大鼠肝功能恢复具有促进作用. 相似文献
17.
Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats 总被引:12,自引:0,他引:12
This study was performed to evaluate the long-term effect on left ventricular function and remodeling in a rat model of bone marrow cell transplantation (BMT) into acute infarcted myocardium. After myocardial infarction was induced in inbred Lewis rats by left anterior descending artery ligation, the ischemic area was directly injected with saline, peripheral blood mononuclear cells (PB-MNCs) or bone marrow mononuclear cells (BM-MNCs). Cardiac function and structure were evaluated by echocardiography before the operation, and on day 1 and 2 months post-infarct. The collagen content, the number of vessels and the vasculogenesis were examined by histology and immunohistochemistry. We found at 2 months post-infarct, BMT significantly improved cardiac systolic function and recovered diastolic function. Transplantation of BM-MNCs, but not PB-MNCs, reversed remodeling and reduced collagen density. Vessel counts showed greater angiogenesis occurred in the animals transplanted with BM-MNCs. Furthermore, a vascular endothelial cell-specific marker was detected in the transplanted bone marrow cells. Our data suggest that BM-MNC transplantation results in long-term improvement in left ventricular function-especially diastolic function- and remodeling, possibly related with the reduction of the amount of the collagen and enhancement of neovascularization. 相似文献
18.
Wang Z Liu F Tu W Chang Y Yao J Wu W Jiang X He X Lin J Song Y 《Journal of cellular and molecular medicine》2012,16(1):118-128
Transforming growth factor (TGF) β(1) plays a critical role in liver fibrosis. Previous studies demonstrated embryonic liver fodrin (ELF), a β-spectrin was involved in TGF-β/Smad signalling pathway as Smad3/4 adaptor. Here we investigate the role of ELF in pathogenesis of liver cirrhosis. In carbon tetrachloride (CCl(4))-induced mice model of liver cirrhosis, ELF is up-regulated in activated hepatic stellate cells (HSCs), and down-regulated in regenerative hepatocytes of cirrhotic nodules. In activated HSCs in vitro, reduction of ELF expression mediated by siRNA leads to the inhibition of HSC activation and procollagen I expression. BrdU assay demonstrates that down-regulation of ELF expression does not inhibit proliferation of activated HSCs in vitro. Immunostaining of cytokeratin 19 and Ki67 indicates that regenerative hepatocytes in cirrhotic liver are derived from hepatic progenitor cells (HPC). Further study reveals that HPC expansion occurs as an initial phase, before the reduction of ELF expression in regenerative hepatocytes. Regenerative hepatocytes in cirrhotic liver show the change in proliferative activity and expression pattern of proteins involved in G1/S transition, which suggests the deregulation of cell cycle in regenerative hepatocytes. Finally, we find that ELF participates in TGF-β/Smad signal in activated HSCs and hepatocytes through regulating the localization of Smad3/4. These data reveal that ELF is involved in HSC activation and the formation of regenerative nodules derived from HPC in cirrhotic liver. 相似文献
19.
20.
Naughton BA Román JS Sibanda B Weintraub JP Kamali V 《Biotechnology and bioengineering》1994,43(8):810-825
Stromal cell-associated liver cell and bone marrow (BM) culture on three-dimensiional nylon screen or polyglycolic acid (PGA) felt templates conveys certain functional advantages to the parenchyma of these tissues. Hepatic parenchymal cells (PC) manifest long-term ( approximately 2 month) expression of liver-specific activities including cytochrome P450 enzyme activity and the synthesis of albumin, fibrinogen, transferrin, and other proteins. PC also undergo proliferation in association with stromal cells that were pre-established on these templates. PC mitoses are directly proportional to available space within the template for their expansion indication that geometric or sterotypic parameters influence the growth of these cells in vitro. BM cultured on a similar template exhibits long-term multilineage hematopoietic expression and limited expansion of progenitor cell numbers. Progenitor cell concentration within the cultures can be substantially enhanced if these cells are liberated from co-culture and reseeded onto a template containing fresh stromal cells. BM and liver cel cultures established on felt composed of bioresorbable PGA filaments was grafted into various sites in rats. Liver co-cultures generated sinusoids and other liver-like structures in situ; active hematopoietic blasts were observed at sites of BM co-culture grafts. Biodegradable polymer constructs may prove useful for certain clinical applications as vehicles for the delivery of tissues that were engineered in culture. 相似文献